Furthermore, exploring the physiological and metabolic implications of modulated GLUT5 expression within various dietary and developmental contexts may provide insights into the roles of glucocorticoids and ChREBP signaling in metabolic diseases and disorders. The gene discussed is SLC2A5; the disease is Other metabolic disease.